ALVO on Nasdaq
Alvotech
Price unavailable
Last updated Oct 16, 2026.
Overview
$27.9MNet income, fiscal 20252
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
-$114.7MFree cash flow2
Financial statements
No quarterly figures reported.
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Product and service revenue | $276.3M | $273.5M | $48.7M |
| License and other revenue | $310.1M | $216.2M | $42.7M |
| Other income | $2.6M | $2.3M | $1.9M |
| Cost of product and service revenue | -$235.6M | -$185.3M | -$160.9M |
| Research and development expenses | -$184.2M | -$171.3M | -$210.8M |
| General and administrative expenses | -$90.9M | -$65.7M | -$76.6M |
| Operating profit | $78.2M | $69.6M | -$354.9M |
| Share of net loss of joint venture | $0 | $0 | -$7.2M |
| Impairment loss on investment in joint venture | $0 | $0 | -$21.5M |
| Loss on sale of interest in joint venture | $0 | -$3.0M | $0 |
| Effects resulting from business combination | $8.0M | $0 | $0 |
| Finance income | $198.5M | $80.1M | $4.8M |
| Finance costs | -$149.2M | -$303.2M | -$267.2M |
| Exchange rate differences | -$16.8M | $8.2M | -$5.2M |
| Net gain / (loss) on modification and extinguishment of financial liabilities | $17.7M | -$69.4M | $0 |
| Non-operating profit / (loss) | $58.1M | -$287.2M | -$296.2M |
| Profit / (loss) before taxes | $136.3M | -$217.6M | -$651.0M |
| Income tax (expense) benefit | -$108.4M | -$14.3M | $99.3M |
| Profit / (loss) for the year | $27.9M | -$231.9M | -$551.7M |
| Exchange rate differences on translation of foreign operations | $3.6M | -$690.0K | -$86.0K |
| Total comprehensive profit / (loss) | $31.5M | -$232.6M | -$551.8M |
| Basic profit / (loss) for the period per share (in dollars per share) | $0.10 | -$0.87 | -$2.43 |
No quarterly figures reported.
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Property, plant and equipment | $356.4M | $284.5M | |
| Right-of-use assets | $138.3M | $125.2M | $119.8M |
| Goodwill | $12.8M | $11.3M | $12.1M |
| Other intangible assets | $81.8M | $20.6M | |
| Contract assets | $122.9M | $22.7M | |
| Other long-term assets | $8.6M | $3.6M | |
| Deferred tax assets | $192.2M | $298.4M | |
| Total non-current assets | $913.1M | $766.4M | |
| Inventories | $220.1M | $127.9M | |
| Trade receivables | $69.7M | $160.2M | |
| Contract assets | $64.4M | $67.3M | |
| Other current assets | $47.0M | $48.1M | |
| Receivables from related parties | $438.0K | $118.0K | |
| Cash and cash equivalents | $172.4M | $51.4M | $11.2M |
| Total current assets | $574.0M | $455.0M | |
| Total assets | $1.5B | $1.2B | |
| Share capital | $2.9M | $2.8M | |
| Share premium | $2.1B | $2.0B | |
| Other reserves | $15.3M | $17.3M | |
| Translation reserve | $1.4M | -$2.2M | |
| Accumulated deficit | -$2.4B | -$2.4B | |
| Total equity | -$284.5M | -$412.8M | -$932.5M |
| Borrowings | $1.3B | $1.0B | |
| Derivative financial liabilities | $54.0M | $210.2M | |
| Lease liabilities | $138.0M | $112.1M | |
| Contract liabilities | $5.5M | $80.7M | |
| Deferred tax liability | $7.9M | $1.8M | |
| Total non-current liabilities | $1.5B | $1.4B | |
| Trade and other payables | $126.1M | $67.1M | |
| Lease liabilities | $12.1M | $9.5M | |
| Current maturities of borrowings | $36.9M | $32.7M | |
| Liabilities to related parties | $3.3M | $8.5M | |
| Contract liabilities | $30.4M | $16.0M | |
| Taxes payable | $1.0M | $204.0K | |
| Other current liabilities | $94.2M | $59.4M | |
| Total current liabilities | $304.1M | $193.4M | |
| Total liabilities | $1.8B | $1.6B | |
| Total equity and liabilities | $1.5B | $1.2B |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Profit / (loss) for the year | $27.9M | -$231.9M | -$551.7M |
| Long-term incentive plan expense | $0 | $0 | $78.0K |
| Depreciation, amortization and impairment | $37.9M | $31.3M | $24.2M |
| Impairment of other intangible assets | $0 | $0 | $1.8M |
| Impairment loss on investment in joint venture | $0 | $0 | $21.5M |
| Change in allowance for receivables | $703.0K | -$946.0K | $18.5M |
| Change in inventory reserves | $646.0K | -$3.5M | $8.3M |
| Share-based payments | $7.4M | $7.6M | $18.0M |
| Loss on disposal of property, plant and equipment | $0 | $0 | $365.0K |
| Effects resulting from business combination | -$8.0M | $0 | $0 |
| Loss on sale of interest in joint venture | $0 | $3.0M | $0 |
| Share of net loss of joint venture | $0 | $0 | $7.2M |
| Finance income | -$198.5M | -$80.1M | -$4.8M |
| Finance costs | $149.2M | $303.2M | $267.2M |
| Exchange rate difference | $16.8M | -$8.2M | $5.2M |
| Net (gain) / loss on modification and extinguishment of financial liabilities | -$17.7M | $69.4M | $0 |
| Income tax expense / (benefit) | $108.4M | $14.3M | -$99.3M |
| Operating cash flow before movement in working capital | $124.8M | $104.1M | -$283.6M |
| Increase in inventories | -$90.1M | -$50.0M | -$11.3M |
| Decrease / (increase) in trade receivables | $93.2M | -$119.1M | -$8.3M |
| (Decrease) increase in receivables with related parties | -$320.0K | $20.0K | $881.0K |
| Increase in contract assets | -$94.9M | -$45.2M | -$17.4M |
| Increase in other assets | -$4.2M | -$7.1M | -$802.0K |
| Increase / (decrease) in trade and other payables | $45.3M | -$13.7M | $31.8M |
| (Decrease) / increase in contract liabilities | -$69.3M | -$31.4M | $35.4M |
| (Decrease) / increase in liabilities with related parties | -$2.2M | -$7.9M | $1.3M |
| Increase / (decrease) in other liabilities | $5.1M | -$14.3M | -$5.2M |
| Cash from (used in) operations | $7.1M | -$184.5M | -$257.2M |
| Interest received | $2.4M | $4.6M | $3.6M |
| Interest paid | -$59.0M | -$54.9M | -$57.3M |
| Income tax paid | -$780.0K | -$2.0M | -$1.4M |
| Net cash used in operating activities | -$50.2M | -$236.8M | -$312.2M |
| Acquisition of property, plant and equipment | -$64.5M | -$53.7M | -$33.2M |
| Disposal of property, plant and equipment | $0 | $0 | $133.0K |
| Acquisition of intangible assets | -$31.7M | -$3.3M | -$13.2M |
| Restricted cash in connection with debt extinguishment | $0 | $26.1M | $0 |
| Net cash outflow on acquisition of subsidiary | -$14.0M | $0 | $0 |
| Proceeds from the sale in joint venture | $6.0M | $12.0M | $0 |
| Net used in investing activities | -$104.2M | -$18.9M | -$46.3M |
| Repayments of borrowings | -$25.4M | -$749.1M | -$99.4M |
| Repayments of principal portion of lease liabilities | -$10.4M | -$10.2M | -$8.3M |
| Proceeds from new borrowings | $233.5M | $896.3M | $278.8M |
| Transaction cost from new borrowings | -$5.6M | -$4.2M | -$9.0M |
| Gross proceeds from equity offering | $82.5M | $150.5M | $136.9M |
| Fees from equity offering | -$3.8M | -$5.8M | -$4.1M |
| Proceeds from warrants | $0 | $4.8M | $6.4M |
| Stock options exercised | $0 | $76.0K | $0 |
| Proceeds from loans from related parties | $0 | $24.5M | $0 |
| Repayment of loans from related parties | $0 | -$9.5M | $0 |
| Net cash generated from financing activities | $270.8M | $297.3M | $301.3M |
| (Decrease) increase in cash and cash equivalents | $116.4M | $41.6M | -$57.2M |
| Effect of movements in exchange rates on cash held | $4.5M | -$1.3M | $1.9M |
Former names
- Alvotech Lux Holdings S.A.S.Dec 20, 2021 to May 2, 20223
Recent filings
- Oct 14, 20266-K
- Oct 7, 20266-K
- Oct 5, 20266-K
- Aug 31, 20266-K
- Aug 21, 20266-K
- Aug 19, 20266-K
- Jul 29, 20266-K
- Jul 1, 20266-K
- Jun 30, 2026SCHEDULE 13D/A
- Jun 18, 20266-K
- Jun 17, 20266-K
- Jun 16, 2026FWP
- Jun 16, 2026424B5
- Jun 15, 20266-K
- Jun 15, 2026424B5
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAlvotech filings on SEC EDGAR
- 2SEC EDGARAlvotech 10-K for fiscal 2025
- 3SEC EDGARAlvotech filings on SEC EDGAR
- 4SEC EDGARAlvotech 10-K for fiscal 2020
- 5SEC EDGARAlvotech 10-K for fiscal 2021
- 6SEC EDGARAlvotech 10-K for fiscal 2022